Skip to Content

KADIAN 30 mg (Morphine Sulfate Extended Release 30 mg)

Pill with imprint KADIAN 30 mg is Purple, Capsule-shape and has been identified as Morphine Sulfate Extended Release 30 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 30 mg

Morphine sulfate extended release 30 mg KADIAN 30 mg
Morphine sulfate extended release 30 mg KADIAN 30 mg
Morphine sulfate extended release 30 mg KADIAN 30 mg
Morphine sulfate extended release 30 mg KADIAN 30 mg

Morphine Sulfate Extended Release

Imprint
KADIAN 30 mg
Strength
30 mg
Color
Purple
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis

Labelers / Repackagers

NDC CodeLabeler / Repackager
00228-3503 Actavis Pharma, Inc.
49884-0834 Par Pharmaceutical, Inc.
52544-0032 Watson Pharmaceuticals, Inc.
54868-4981 Physicians Total Care Inc. (repackager)
35356-0049 Lake Erie Medical and Surgical Supply (repackager)
68071-0345 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "KADIAN 30 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.